Future interventions that selectively modulate neutrophil activation, ROS generation, or NET formationsuch as PAD4 inhibitors, ROS scavengers, DNase-based therapies, or blockade of neutrophilplatelet interactionshold promise to shift PCOS management from symptomatic hormone modulation toward precision immuno-metabolic therapy
Campagna MC, Taketa T, Correa AM, Sudo K, Blum MA, Wadhwa R, Komaki R, Lee JH, Bhutani MS, Weston B, Liao ZX, Rice DC , Swisher S, Hofstetter WL, Ajani JA
I'm sure you saw that Stephen Crowder thing where he caught that Covid czar guy
This EMI option is available to you without any added processing fees
Am J Kidney Dis 26(5):757764